95 related articles for article (PubMed ID: 715485)
1. Vincristine-induced dysphagia.
Chisholm RC; Curry SB
South Med J; 1978 Nov; 71(11):1364-5. PubMed ID: 715485
[TBL] [Abstract][Full Text] [Related]
2. Vincristine-induced dysphagia suggesting esophageal motor dysfunction: a case report.
Wang WS; Chiou TJ; Liu JH; Fan FS; Yen CC; Chen PM
Jpn J Clin Oncol; 2000 Nov; 30(11):515-8. PubMed ID: 11155923
[TBL] [Abstract][Full Text] [Related]
3. [Recurrent laryngeal nerve palsy and dysphagia for liquids due to vincristine].
Manelis G; Aderka D; Manelis J; Horn I
Harefuah; 1976 Aug; 91(3-4):84-5. PubMed ID: 976843
[No Abstract] [Full Text] [Related]
4. Combination chemotherapy of metastatic breast cancer with vincristine adriamycin and prednisolone.
Russell JA; Baker JW; Dady PJ; Ford HT; Gazet JC; McKinna JA; Nash AG; Powles TJ
Cancer; 1978 Feb; 41(2):396-9. PubMed ID: 630530
[TBL] [Abstract][Full Text] [Related]
5. Combination versus sequential five-drug chemotherapy in metastatic carcinoma of the breast.
Smalley RV; Murphy S; Huguley CM; Bartolucci AA
Cancer Res; 1976 Nov; 36(11 Pt 1):3911-6. PubMed ID: 975039
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
[TBL] [Abstract][Full Text] [Related]
7. Vincristine with high-dose etoposide in advanced breast cancer: a phase II trial of the Piedmont Oncology Association.
Thomas GW; Muss HB; Jackson DV; McCulloch J; Ramseur W; McFarland J; Hoen H; Pavy M; Heath R
Cancer Chemother Pharmacol; 1994; 35(2):165-8. PubMed ID: 7987995
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of hexamethylmelamine alone and in combination with mitomycin C and vincristine in advanced breast carcinoma.
Legha SS; Buzdar AU; Hortobagyi GN; DiStefano A; Wiseman CL; Yap HY; Blumenschein GR; Bodey GP
Cancer Treat Rep; 1979; 63(11-12):2053-6. PubMed ID: 118805
[TBL] [Abstract][Full Text] [Related]
9. Augmentation of vincristine-induced thrombocytosis by norethisterone.
Cantwell BM; Begent RH; Rubens RD
Eur J Cancer (1965); 1979 Aug; 15(8):1065-9. PubMed ID: 510343
[No Abstract] [Full Text] [Related]
10. Chemotherapy of metastatic breast cancer in postmenopausal women: a controlled trial of cyclophosphamide versus a five-drug combination of cyclophosphamide, vincristine, methotrexate, 5-fluorouracil and prednisone.
Mouridsen HT; Palshof T
Prog Clin Biol Res; 1977; 12():459-66. PubMed ID: 335404
[No Abstract] [Full Text] [Related]
11. A comparative randomized trial of vinca alkaloids in patients with metastatic breast carcinoma.
Yau JC; Yap YY; Buzdar AU; Hortobagyi GN; Bodey GP; Blumenschein GR
Cancer; 1985 Jan; 55(2):337-40. PubMed ID: 3880657
[TBL] [Abstract][Full Text] [Related]
12. A preliminary analysis of combination therapy with vincristine, adriamycin, and prednimustine (VAP) in advanced breast cancer: a phase II study.
Lehnert M; Biffl G; Wascher H; Jordis-Lohausen K; Wählby S
Semin Oncol; 1986 Mar; 13(1 Suppl 1):32-4. PubMed ID: 3754064
[TBL] [Abstract][Full Text] [Related]
13. Optic atrophy induced by vincristine.
Shurin SB; Rekate HL; Annable W
Pediatrics; 1982 Aug; 70(2):288-91. PubMed ID: 7099798
[TBL] [Abstract][Full Text] [Related]
14. Combination chemotherapy for disseminated carcinoma of the breast.
Lozada JA; Grillo-López A; Vélez-Garciá E
Bol Asoc Med P R; 1975 Jun; 67(6):157-63. PubMed ID: 1055588
[No Abstract] [Full Text] [Related]
15. Polychemotherapeutic treatment of patients with metastatic breast cancer.
Balázs M; Tüske M
Acta Med Hung; 1986; 43(4):407-11. PubMed ID: 3601586
[TBL] [Abstract][Full Text] [Related]
16. Combination chemotherapy of advanced breast cancer. Comparison of dibromodulcitol, doxorubicin, vincristine, and fluoxymesterone to thiotepa, doxorubicin, vinblastine, and fluoxymesterone: an Eastern Cooperative Oncology Group Study.
Skeel RT; Andersen JW; Tormey DC; Benson AB; Asbury RF; Falkson G
Cancer; 1989 Oct; 64(7):1393-9. PubMed ID: 2505919
[TBL] [Abstract][Full Text] [Related]
17. Combination chemotherapy in advanced breast cancer.: a randomized trial comparing a three-vs a five-drug program.
Muss HB; White DR; Cooper MR; Richards F; Spurr CL
Arch Intern Med; 1977 Dec; 137(12):1711-4. PubMed ID: 337916
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of VP-16 and the combination of adriamycin and vincristine in advanced breast cancer.
Eagan RT; Ahmann DL; Bisel HF
Oncology; 1976; 33(3):146-8. PubMed ID: 1012648
[TBL] [Abstract][Full Text] [Related]
19. Failure of scalp hypothermia to prevent hair loss when cyclophosphamide is added to doxorubicin and vincristine.
Middleton J; Franks D; Buchanan RB; Hall V; Smallwood J; Williams CJ
Cancer Treat Rep; 1985 Apr; 69(4):373-5. PubMed ID: 3995509
[TBL] [Abstract][Full Text] [Related]
20. Combination chemotherapy with adriamycin (NSC-123127) in metastatic mammary carcinoma.
Brambilla C; De Lena M; Bonadonna G
Cancer Chemother Rep; 1974; 58(2):251-3. PubMed ID: 4598244
[No Abstract] [Full Text] [Related]
[Next] [New Search]
